These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36094917)

  • 1. Design and development of a self-assembling protein nanoparticle displaying PfHAP2 antigenic determinants recognized by natural acquired antibodies.
    Zahedi F; Abouie Mehrizi A; Sardari S; Alemzadeh I
    PLoS One; 2022; 17(9):e0274275. PubMed ID: 36094917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited genetic diversity and purifying selection in Iranian Plasmodium falciparum Generative Cell Specific 1 (PfGCS1), a potential target for transmission-blocking vaccine.
    Mehrizi AA; Zakeri S; Djadid ND
    Infect Genet Evol; 2014 Mar; 22():150-6. PubMed ID: 24462906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.
    Karch CP; Doll TAPF; Paulillo SM; Nebie I; Lanar DE; Corradin G; Burkhard P
    J Nanobiotechnology; 2017 Sep; 15(1):62. PubMed ID: 28877692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine.
    Guo Q; Dasgupta D; Doll TA; Burkhard P; Lanar DE
    Methods; 2013 May; 60(3):242-7. PubMed ID: 23548672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
    Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria vaccine based on self-assembling protein nanoparticles.
    Burkhard P; Lanar DE
    Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.
    Kaba SA; Brando C; Guo Q; Mittelholzer C; Raman S; Tropel D; Aebi U; Burkhard P; Lanar DE
    J Immunol; 2009 Dec; 183(11):7268-77. PubMed ID: 19915055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation.
    Karch CP; Burkhard P; Matyas GR; Beck Z
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31498330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.
    Seth L; Bingham Ferlez KM; Kaba SA; Musser DM; Emadi S; Matyas GR; Beck Z; Alving CR; Burkhard P; Lanar DE
    Vaccine; 2017 Oct; 35(41):5448-5454. PubMed ID: 28274638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
    Miura K; Takashima E; Deng B; Tullo G; Diouf A; Moretz SE; Nikolaeva D; Diakite M; Fairhurst RM; Fay MP; Long CA; Tsuboi T
    Infect Immun; 2013 Dec; 81(12):4377-82. PubMed ID: 24042109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.
    Terheggen U; Drew DR; Hodder AN; Cross NJ; Mugyenyi CK; Barry AE; Anders RF; Dutta S; Osier FH; Elliott SR; Senn N; Stanisic DI; Marsh K; Siba PM; Mueller I; Richards JS; Beeson JG
    BMC Med; 2014 Oct; 12():183. PubMed ID: 25319190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
    Wahome N; Pfeiffer T; Ambiel I; Yang Y; Keppler OT; Bosch V; Burkhard P
    Chem Biol Drug Des; 2012 Sep; 80(3):349-57. PubMed ID: 22650354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the heterologous expression and purification of Plasmodium falciparum generative cell specific 1 in Escherichia coli.
    Ayoub Meigouni M; Abouie Mehrizi A; Fazaeli A; Zakeri S; Djadid ND
    Protein Expr Purif; 2022 Oct; 198():106126. PubMed ID: 35661702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.
    Feng G; Boyle MJ; Cross N; Chan JA; Reiling L; Osier F; Stanisic DI; Mueller I; Anders RF; McCarthy JS; Richards JS; Beeson JG
    J Infect Dis; 2018 Jun; 218(1):35-43. PubMed ID: 29584918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine.
    Kaba SA; Karch CP; Seth L; Ferlez KMB; Storme CK; Pesavento DM; Laughlin PY; Bergmann-Leitner ES; Burkhard P; Lanar DE
    Vaccine; 2018 Feb; 36(6):906-914. PubMed ID: 29269157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
    Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P
    Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
    Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
    Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.